Aura Biosciences Inc.

NASDAQ: AURA · Real-Time Price · USD
6.73
-0.27 (-3.86%)
At close: Aug 15, 2025, 3:59 PM
6.85
1.78%
After-hours: Aug 15, 2025, 05:02 PM EDT

Aura Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
31.69M 41.06M 121.58M 149.06M
Short-Term Investments
119.4M 185.09M 67.23M n/a
Long-Term Investments
n/a n/a 768K 125K
Other Long-Term Assets
1.29M 1.28M 423K n/a
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
1.83M 2.43M 5.72M 1.91M
Total Current Assets
160.62M 231.79M 196.7M 153.7M
Property-Plant & Equipment
20.59M 22M 26.04M 6.2M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
21.88M 23.28M 27.23M 6.33M
Total Assets
182.5M 255.07M 223.94M 160.03M
Account Payables
2.3M 1.79M 2.92M 2.4M
Deferred Revenue
n/a n/a n/a 3.83M
Short-Term Debt
3.15M n/a 2.96M 615K
Other Current Liabilities
4M 4.38M 67K 1.49M
Total Current Liabilities
14.91M 12.36M 10.46M 7.27M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
15.62M 16.87M 17.89M 443K
Total Liabilities
30.53M 29.23M 28.35M 7.71M
Total Debt
18.77M 19.56M 20.86M 975K
Common Stock
n/a n/a n/a n/a
Retained Earnings
-374.23M -287.31M -210.9M -152.14M
Comprehensive Income
263K 539K -72K n/a
Shareholders Equity
151.97M 225.85M 195.58M 152.31M
Total Investments
119.4M 185.09M 67.23M 125K